DIL Limited (formerly known as Fermenta Biotech Limited) is a significant player in the global market as one of the largest manufacturers of Vitamin D3. The company is based in Thane, India, with a widespread distribution network that caters to clients worldwide. DIL Limited boasts a state-of-the-art R&D center in Thane along with world-class manufacturing facilities located in Kullu, Himachal Pradesh and Dahej, Gujarat. In addition to Vitamin D3, the company also provides a range of niche APIs and integrated biotechnology platforms, including enzymes for antibiotic synthesis, along with environmental solutions for wastewater management and treatment.
This diversified product portfolio positions DIL Limited as a prominent player in the global biotechnology and pharmaceutical industries, offering a broad spectrum of solutions that cater to various market demands. The strategic locations of its manufacturing facilities enable efficient production and distribution capabilities, further solidifying its presence in the global market.
With its strong focus on R&D and cutting-edge technologies, DIL Limited demonstrates a commitment to innovation and sustainable solutions, which underpins its market value and potential for growth. Its established presence in both domestic and international markets, coupled with its diverse product offerings, positions the company as an attractive prospect for potential investors seeking opportunities in the biotechnology and pharmaceutical sectors.
There is no investment information
No recent news or press coverage available for DIL Limited.